- Home
- MVO vs NTRB Comparison
MVO vs NTRB Comparison
Compare MVO & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MVO | NTRB |
|---|---|---|
| Founded | 2006 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Industrial Specialties |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.9M | 57.0M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | MVO | NTRB |
|---|---|---|
| Price | $1.82 | $4.44 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 55.1K | ★ 63.5K |
| Earning Date | 01-01-0001 | 12-11-2025 |
| Dividend Yield | ★ 17.46% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.46 | N/A |
| Revenue | N/A | ★ $2,278,321.00 |
| Revenue This Year | N/A | $30.17 |
| Revenue Next Year | N/A | $3,394.36 |
| P/E Ratio | $7.29 | ★ N/A |
| Revenue Growth | N/A | ★ 12.69 |
| 52 Week Low | $8.85 | $4.17 |
| 52 Week High | $13.95 | $11.78 |
Technical Indicators
Market Signals| Indicator | MVO | NTRB |
|---|---|---|
| Relative Strength Index (RSI) | 53.22 | 49.36 |
| Support Level | $1.55 | $4.25 |
| Resistance Level | $2.42 | $4.74 |
| Average True Range (ATR) | 0.32 | 0.22 |
| MACD | 0.07 | 0.05 |
| Stochastic Oscillator | 57.80 | 71.94 |
Price Performance
Historical ComparisonAbout MVO MV Oil Trust Units of Beneficial Interests
MV Oil Trust is a statutory trust. Its underlying properties consist of MV Partners, LLC's (MV Partners) net interests in all of its oil and natural gas properties, which are located in the Mid-Continent region in the States of Kansas and Colorado. These properties include producing oil and gas wells.
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.